M. Segelmark et al., BINDING AND INHIBITION OF MYELOPEROXIDASE (MPO) - A MAJOR FUNCTION OFCERULOPLASMIN, Clinical and experimental immunology, 108(1), 1997, pp. 167-174
Interactions between plasma proteins and MPO were studied. The protein
fraction of normal plasma and serum was shown to exhibit an inhibitor
y effect on the peroxidase activity of MPO. Most of the inhibitory eff
ect could be retained on an MPO-coupled affinity chromatography column
. In particular, a protein with apparent mel, wt of 130 kD showed affi
nity for MPO. The protein was identified as ceruloplasmin by N-termina
l amino acid sequencing and immunochemistry. During separation procedu
res the peroxidase inhibitory effect was limited to ceruloplasmin-cont
aining fractions of plasma. Purified ceruloplasmin inhibited the perox
idase activity of MPO in a concentration-dependent manner, and exhibit
ed selective binding to MPO-coated microtitre plates. This binding cou
ld be inhibited by MPO dissolved in buffer. Correspondingly the bindin
g of MPO to ceruloplasmin-coated plates could be blocked by ceruloplas
min in solution, showing a physical interaction to occur between the t
wo proteins under physiological conditions. We also found affinity to
exist between MPG and C3 (and its C3d-containing fragments). However,
C3 and C3 fragments did not inhibit the peroxidase reaction in vitro.
We propose that ceruloplasmin takes part in the clearance and inactiva
tion of MPG, in vivo. We also speculate that impaired inactivation of
MPO may have a pathophysiological role in inflammatory diseases charac
terized by autoantibodies to MPG, such as rapidly progressive glomerul
onephritis with P-ANCA (perinuclear anti-neutrophil cytoplasmic antibo
dies).